Guo Chuan-Yong, Wu Jian-Ye, Wu Yun-Bin, Zhong Min-Zhang, Lu Han-Ming
Department of Gastroenterology, Shanghai Tenth People Hospital of Tongji University, Shanghai 200072, China.
World J Gastroenterol. 2004 Sep 15;10(18):2697-700. doi: 10.3748/wjg.v10.i18.2697.
To explore the effects of endothelin-1(ET-1) on hepatic stellate cells (HSCs) DNA uptake, DNA synthesis, collagen synthesis and secretion, inward whole-cell calcium concentration ([Ca2+]i) as well as the blocking effect of verapamil on ET-1-stimulated release of inward calcium (Ca2+) of HSC in vitro.
Rat hepatic stellate cells (HSCs) were isolated and cultivated. 3H-TdR and 3H-proline incorporation used for testing DNA uptake and synthesis, collagen synthesis and secretion of HSCs cultured in vitro; Fluorescent calcium indicator Fura-2/AM was used to measure [Ca2+]i inward HSCs.
ET-1 at the concentration of 5X10(-8) mol/L, caused significant increase both in HSC DNA synthesis (2,247+/-344 cpm, P<0.05) and DNA uptake (P<0.05) when compared with the control group. ET-1 could also increase collagen synthesis (P<0.05 vs control group) and collagen secretion (P<0.05 vs control group). Besides, inward HSC [Ca2+]i reached a peak concentration (422+/-98 mol/L, P<0.001) at 2 min and then went down slowly to 165+/-51 mol/L (P<0.01) at 25 min from resting state (39+/-4 mol/L) after treated with ET-1. Verapamil (5 mol/L) blocked ET-1-activated [Ca2+]i inward HSCs compared with control group (P<0.05). Fura-2/AM loaded HSC was suspended in no Ca2+ buffer containing 1 mol/L EGTA, 5 min later, 10(-8) mol/L of ET-1 was added, [Ca2+]i inward HSCs rose from resting state to peak 399+/-123 mol/L, then began to come down by the time of 20 min. It could also raise [Ca2+]i inward HSCs even without Ca2+ in extracellular fluid, and had a remarkable dose-effect relationship(P<0.05). Meanwhile, verapamil could restrain the action of ET-1(P<0.05).
Actions of ET-1 on collagen metabolism of HSCs may depend on the transportation of inward whole-cell calcium.
探讨内皮素-1(ET-1)对肝星状细胞(HSCs)DNA摄取、DNA合成、胶原蛋白合成与分泌、细胞内全钙浓度([Ca2+]i)的影响,以及维拉帕米对ET-1刺激的HSCs细胞内钙(Ca2+)释放的阻断作用。
分离培养大鼠肝星状细胞(HSCs)。采用3H-胸腺嘧啶核苷(3H-TdR)和3H-脯氨酸掺入法检测体外培养的HSCs的DNA摄取、合成、胶原蛋白合成与分泌;用荧光钙指示剂Fura-2/AM检测HSCs细胞内[Ca2+]i。
与对照组相比,5×10(-8)mol/L的ET-1可使HSC DNA合成(2247±344 cpm,P<0.05)和DNA摄取显著增加(P<0.05)。ET-1还可增加胶原蛋白合成(与对照组相比,P<0.05)和胶原蛋白分泌(与对照组相比,P<0.05)。此外,ET-1处理后,HSCs细胞内[Ca2+]i在2分钟时达到峰值浓度(422±98 mol/L,P<0.001),然后从静息状态(39±4 mol/L)缓慢下降至25分钟时的165±51 mol/L(P<0.01)。与对照组相比,维拉帕米(5 μmol/L)可阻断ET-1激活的HSCs细胞内[Ca2+]i升高(P<0.05)。将负载Fura-2/AM的HSCs悬浮于含1 mmol/L乙二醇双四乙酸(EGTA)的无钙缓冲液中,5分钟后加入10(-8)mol/L的ET-1,HSCs细胞内[Ca2+]i从静息状态升至峰值399±123 mol/L,然后在20分钟时开始下降。即使细胞外液无钙,ET-1也可使HSCs细胞内[Ca2+]i升高,且具有显著的剂量效应关系(P<0.05)。同时,维拉帕米可抑制ET-1的作用(P<0.05)。
ET-1对HSCs胶原蛋白代谢的作用可能依赖于细胞内全钙的转运。